Health Care & Life Sciences » Pharmaceuticals | Heron Therapeutics Inc.

Heron Therapeutics Inc.

Heron Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.47
Market Cap
$1.45 B
Shares Outstanding
79.19 M
Public Float
77.53 M

Profile

Address
4242 Campus Point Court
San Diego California 92121
United States
Employees -
Website http://www.herontx.com
Updated 07/08/2019
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011.

Financials

View All
Created with Highcharts 5.0.14Heron Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.55 28355 28376 36776 36797 59197 591173 143173 143197 484197 484178 840178 840201320142015201620172018050k100k150k200k250k
Created with Highcharts 5.0.14Heron Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000001 2791 27930 76730 76777 47477 474201320142015201620172018020k40k60k80k100k

Kevin C. Tang
Chairman
Robert H. Rosen
President & Director